348
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and optimization of nilotinib self-micro-emulsifying drug delivery systems to enhance oral bioavailability

, , , , & ORCID Icon
Pages 498-504 | Received 14 Oct 2019, Accepted 31 Jan 2020, Published online: 02 Mar 2020

References

  • Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2000;44:235–249.
  • Weuts I, Kempen D, Decorte A, et al. Phase behavior analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. Eur J Pharm Sci. 2004;22:375–385.
  • Ammar HO, Salama HA, Ghorab M, et al. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. Int J Pharm. 2006;320:53–57.
  • Ghosh PK, Murthy RS. Microemulsions: a potential drug delivery system. Curr Drug Deliv. 2006;3:167–180.
  • Bhamidipati PK, Kantarjian H, Cortes J, et al. Management of imatinib-resistant patients with chronic myeloid leukemia. Ther Adv Hematol. 2013;4:103–117.
  • Weisberg E, Manley P, Mestan J, et al. AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL. Br J Cancer. 2006;94:1765–1769.
  • Herbrink M, Schellens JHM, Beijnen JH, et al. Improving the solubility of nilotinib through novel spray-dried solid dispersions. Int J Pharm. 2017;529:294–302.
  • Shen H, Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2006;58:1183–1191.
  • Higuchi T, Shih FM, Kimura T, et al. Solubility determination of barely aqueous-soluble organic solids. J Pharm Sci. 1979;68:1267–1272.
  • Pirro E, De Francia S, De Martino F, et al. A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. J Chromatogr Sci. 2011;49:753–757.
  • Zeng J, Cai HL, Jian ZP, et al. A validated UPLC–MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma. J Pharm Anal. 2017;7:374–380.
  • Pandey V, Kohli S. SMEDDS of pioglitazone: formulation, in-vitro evaluation and stability studies. Future J Pharm Sci. 2017;3:53–59.
  • Craig DQM, Lievens HSR, Pitt KG, et al. An investigation into the physicochemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm. 1993;96:147–155.
  • Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212:233–246.
  • Saurabh SS, Issarani R, Bp N. Formulation and evaluation of self-emulsifying drug delivery system of etoricoxib. Asian J Pharm Clin Res. 2017;10:367–372.
  • Gupta S, Kesarla R, Omri A. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm. 2013;2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.